PIPS Key Facts
            
                | Active Substance | 
                
                                            
                                                            - Pneumococcal Polysaccharide Serotype 6A conjugated to CRM197 carrier protein and adsorbed on aluminium Phosphate
 
                                                            - Pneumococcal Polysaccharide Serotype 14 conjugated to CRM197 carrier protein and adsorbed on aluminium Phosphate
 
                                                            - Pneumococcal Polysaccharide Serotype 3 conjugated to CRM197 carrier protein and adsorbed on aluminium Phosphate
 
                                                            - Pneumococcal Polysaccharide Serotype 12F conjugated to CRM197 carrier protein and adsorbed on aluminium Phosphate
 
                                                            - Pneumococcal Polysaccharide Serotype 23F conjugated to CRM197 carrier protein and adsorbed on aluminium Phosphate 
 
                                                            - Pneumococcal Polysaccharide Serotype 33F conjugated to CRM197 carrier protein and adsorbed on aluminium Phosphate
 
                                                            - Pneumococcal Polysaccharide Serotype 5 conjugated to CRM197 carrier protein and adsorbed on aluminium Phosphate
 
                                                            - Pneumococcal Polysaccharide Serotype 7F conjugated to CRM197 carrier protein and adsorbed on aluminium Phosphate
 
                                                            - Pneumococcal Polysaccharide Serotype 6B conjugated to CRM197 carrier protein and adsorbed on aluminium Phosphate
 
                                                            - Pneumococcal Polysaccharide Serotype 19A conjugated to CRM197 carrier protein and adsorbed on aluminium Phosphate
 
                                                            - Pneumococcal Polysaccharide Serotype 19F conjugated to CRM197 carrier protein and adsorbed on aluminium Phosphate
 
                                                            - Pneumococcal Polysaccharide Serotype 8 conjugated to CRM197 carrier protein and adsorbed on aluminium Phosphate
 
                                                            - Pneumococcal Polysaccharide Serotype 11A conjugated to CRM197 carrier protein and adsorbed on aluminium Phosphate
 
                                                            - Pneumococcal Polysaccharide Serotype 15B conjugated to CRM197 carrier protein and adsorbed on aluminium Phosphate
 
                                                            - Pneumococcal Polysaccharide Serotype 1 conjugated to CRM197 carrier protein and adsorbed on aluminium Phosphate
 
                                                            - Pneumococcal Polysaccharide Serotype 22F conjugated to CRM197 carrier protein and adsorbed on aluminium Phosphate
 
                                                            - Pneumococcal Polysaccharide Serotype 4 conjugated to CRM197 carrier protein and adsorbed on aluminium Phosphate
 
                                                            - Pneumococcal Polysaccharide Serotype 9V conjugated to CRM197 carrier protein and adsorbed on aluminium Phosphate
 
                                                            - Pneumococcal Polysaccharide Serotype 10A conjugated to CRM197 carrier protein and adsorbed on aluminium Phosphate
 
                                                            - Pneumococcal Polysaccharide Serotype 18C conjugated to CRM197 carrier protein and adsorbed on aluminium Phosphate
 
                                                     
                                     | 
            
            
                
                    Invented Name  
                 | 
                
                                                                    
                                                            - Apexxnar
 
                                                            - Prevnar 20
 
                                                            - Apexxnar 
 
                                                     
                                                             | 
            
            
                | PIP Number | 
                MHRA-100236-PIP01-21-M03 (update) | 
            
            
                | 
                    Pharmaceutical form(s)
                 | 
                
                                             Pharmaceutical form(s): 
                                     | 
            
            
                | 
                    Therapeutic area
                 | 
                
                                             Therapeutic area: 
                                     | 
            
            
                | 
                    Conditions / Indications
                 | 
                
                                             Conditions / Indications: 
      - Prevention of disease caused by Streptococcus pneumoniae
 
   
                                     | 
            
            
                | 
                    Route(s) of administration
                 | 
                
                                             Route(s) of administration: 
                                     | 
            
            
                | 
                    PIP applicant
                 | 
                
                    
                 | 
            
            
                | 
                    Decision Type
                 | 
                
                    
  
    Decision Type 
              PM: decision on the application for modification of an agreed paediatric investigation plan.  
           
                 | 
            
            
                | 
                    Compliance Check
                 | 
                
                    
  
                 | 
            
            
                | 
                    Compliance Check Decision Date
                 | 
                
                    
  
    Compliance opinion date 
              09/08/2023 
           
                 | 
            
            
                | 
                    Compliance Check Procedure Number
                 | 
                
                    
  
    Compliance procedure number 
              MHRA-100236-PIP01-21-M03-C1 
           
                 |